Prevalence and comorbidity of autism spectrum disorder in Spain: study protocol for a systematic review and meta-analysis of observational studies.

BACKGROUND: Autism spectrum disorder (ASD) is a complex developmental disorder characterised by impaired social interaction and communication, and restrictive and repetitive behaviour. Previous systematic reviews have traditionally assessed the prevalence of ASD on global or regional context, with very few meta-analyses at the country level. The objective of this study will be to systematically evaluate published and unpublished observational studies that present prevalence and comorbidity of ASD among children, adolescent and adult population in Spain. METHODS/DESIGN: We designed and registered a study protocol for a systematic review and meta-analysis of descriptive epidemiology data. Observational studies (cohort, cross-sectional) reporting the prevalence of ASD and conducted in a wide range of people (e.g. general population, outpatient and/or school settings) will be included. The primary outcome will be the prevalence of ASD. Secondary outcomes will be the prevalence of any physical or mental comorbidity in association with ASD. No limitations will be imposed on publication status, study conduct period, and language of dissemination. Comprehensive literature searches will be conducted in seven electronic databases (from January 1980 onwards), including PubMed/MEDLINE, EMBASE, Scopus, Web of Science, PsycINFO, IME-Spanish Medical Index and IBECS-Spanish Bibliographic Index of Health Sciences. Grey literature will be identified through searching dissertation databases, Google Scholar and conference abstracts. Two team members will independently screen all citations, full-text articles, and abstract data. Potential conflicts will be resolved through discussion. The study methodological quality (or bias) will be appraised using an appropriate tool. If feasible, we will conduct random effects meta-analysis of observational data. Prevalence estimates will be stratified according to gender, age and geographical location. Additional analyses will be conducted to explore the potential sources of heterogeneity (e.g. methodological quality, sample size, diagnostic criteria). DISCUSSION: This systematic review and meta-analysis of observational data will identify, evaluate and integrate the epidemiological knowledge underlying the prevalence of ASD in Spain. The results of this study will be of interest to multiple audiences including patients, their families, caregivers, healthcare professional, scientists and policy makers. Results will be published in a peer-reviewed journal. Implications for future epidemiological research will be discussed. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42018090372.

Association of Anorexia Nervosa With Risk of Cancer: A Systematic Review and Meta-analysis.

Importance: Anorexia nervosa is recognized as an important cause of morbidity in young people. However, the risk of cancer in people with anorexia nervosa remains uncertain. Objective: To evaluate the association of anorexia nervosa with the risk of developing or dying of cancer. Data Sources: MEDLINE, Scopus, Embase, and Web of Science from database inception to January 9, 2019. Study Selection: Published observational studies in humans examining the risk of cancer in people with anorexia nervosa compared with the general population or those without anorexia nervosa. Studies needed to report incidence or mortality rate ratios (RRs). Data Extraction and Synthesis: Screening, data extraction, and methodological quality assessment were performed by at least 2 researchers independently. A random-effects model was used to synthesize individual studies. Heterogeneity (I2) was assessed and 95% prediction intervals (PIs) were calculated. Main Outcomes and Measures: All cancer incidence and cancer mortality associated with anorexia nervosa. Secondary outcomes were site-specific cancer incidence and mortality. Results: Seven cohort studies published in 10 articles (42 602 participants with anorexia nervosa) were included. Anorexia nervosa was not associated with risk of developing any cancer (4 studies in women; RR, 0.97; 95% CI, 0.89-1.06; P = .53; I2, 0%; 95% PI, 0.80-1.18; moderate confidence). Anorexia nervosa was associated with decreased breast cancer incidence (5 studies in women; RR, 0.60; 95% CI, 0.50-0.80; P < .001; I2, 0%; 95% PI, 0.44-0.83; high confidence). Conversely, anorexia nervosa was associated with increased risk of developing lung cancer (3 studies in women; RR, 1.50; 95% CI, 1.06-2.12; P = .001; I2, 0%; 95% PI, 0.19-16.46; low confidence) and esophageal cancer (2 studies in women; RR, 6.10; 95% CI, 2.30-16.18; P < .001; I2, 0%; low confidence). Conclusions and Relevance: Among people with anorexia nervosa, risk of developing cancer did not differ compared with the general population, but a significantly reduced risk of breast cancer was observed. Understanding the mechanisms underlying these associations could have important preventive potential.

Prevalence and comorbidity of attention deficit hyperactivity disorder in Spain: study protocol for extending a systematic review with updated meta-analysis of observational studies.

BACKGROUND: Attention deficit hyperactivity disorder (ADHD) is a childhood-onset disorder characterized by a persistent pattern of symptoms of developmentally inappropriate and impaired inattention and/or hyperactivity/impulsivity, with difficulties often continuing into adulthood. ADHD can come with other comorbid conditions. The aim of this study will be to quantify the prevalence and comorbidity of ADHD among children, adolescent, and adult population in Spain. METHODS/DESIGN: We designed and registered a study protocol for an update and expansion of a systematic review and meta-analysis of pooled prevalence data. We will include cross-sectional observational studies reporting prevalence of ADHD in Spain and conducted in the general population, outpatient, and/or school settings. The primary outcome will be the prevalence of ADHD. Secondary outcomes will be the prevalence of any physical or mental comorbidity in association with ADHD. No limitations will be imposed on publication status, study conduct period, and language of dissemination. Comprehensive literature searches will be conducted in multiple electronic databases, including PubMed/MEDLINE, EMBASE, Scopus, Web of Science, PsycINFO, IME - Spanish Medical Index, and IBECS - Spanish Bibliographic Index of Health Sciences. We will also search Google Scholar, dissertation databases, and conference abstracts. Two team members will independently screen all citations, full-text articles, and abstract data. Potential conflicts will be resolved through discussion. The methodological quality (or risk of bias) of individual studies will be appraised using an appropriate tool. If feasible, we will conduct random effects meta-analysis. Prevalence estimates will be stratified according to gender, age, and geographical location. Additional analyses will be conducted to explore the potential sources of heterogeneity (e.g., methodological quality, sample size, diagnostic criteria). DISCUSSION: This systematic review and meta-analysis of observational data will provide an updated synthesis of the prevalence and comorbidity of ADHD in Spain. This study will also examine factors that may explain potential variations in prevalence data. The findings of this study will be published in a peer-reviewed journal. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42018106082 .

Anorexia nervosa and cancer: a protocol for a systematic review and meta-analysis of observational studies.

BACKGROUND: Anorexia nervosa is characterized by a severe restriction of caloric intake, low body weight, fear of gaining weight or of becoming fat, and disturbance of body image. Pathogenesis of the disorder may include genetic predisposition, hormonal changes and a combination of environmental, psychosocial, and cultural factors. Cancer is the second leading cause of death worldwide. At present, no systematic reviews and meta-analyses have evaluated the risk of cancer in people with anorexia nervosa. The objective of this study will be to evaluate the association between anorexia nervosa and the risk of developing or dying from cancer. METHODS/DESIGN: This study protocol is part of a systematic collection and assessment of multiple systematic reviews and meta-analyses (umbrella review) evaluating the association of cancer and multiple central nervous system disorders. We designed a specific protocol for a new systematic review and meta-analysis of observational studies of anorexia nervosa with risk of developing or dying from any cancer. Data sources will be PubMed, Embase, Scopus, Web of Science, and manual screening of references. Observational studies (case-control and cohort) in humans that examined the association between anorexia nervosa and risk of developing or dying from cancer will be sought. The primary outcomes will be cancer incidence and cancer mortality in association with anorexia nervosa. Secondary outcomes will be site-specific cancer incidence and mortality, respectively. Screening of abstracts and full texts, and data abstraction will be performed by two team members independently. Conflicts at all levels of screening and abstraction will be resolved through discussion. The quality of studies will be assessed by using the Ottawa-Newcastle scale by two team members independently. Random effects models will be conducted where appropriate. Subgroup and additional analyses will be conducted to explore the potential sources of heterogeneity. The World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) criteria and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach will be used for determining the quality of evidence for cancer outcomes. DISCUSSION: Findings from this systematic review will inform an ongoing umbrella review on cancer and central nervous system disorders. Our systematic review and meta-analysis of observational studies will establish the extent of the epidemiological evidence underlying the association between anorexia nervosa and cancer. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42017067462.

Cancer and central nervous system disorders: protocol for an umbrella review of systematic reviews and updated meta-analyses of observational studies.

BACKGROUND: The objective of this study will be to synthesize the epidemiological evidence and evaluate the validity of the associations between central nervous system disorders and the risk of developing or dying from cancer. METHODS/DESIGN: We will perform an umbrella review of systematic reviews and conduct updated meta-analyses of observational studies (cohort and case-control) investigating the association between central nervous system disorders and the risk of developing or dying from any cancer or specific types of cancer. Searches involving PubMed/MEDLINE, EMBASE, SCOPUS and Web of Science will be used to identify systematic reviews and meta-analyses of observational studies. In addition, online databases will be checked for observational studies published outside the time frames of previous reviews. Eligible central nervous system disorders will be Alzheimer's disease, anorexia nervosa, amyotrophic lateral sclerosis, autism spectrum disorders, bipolar disorder, depression, Down's syndrome, epilepsy, Huntington's disease, multiple sclerosis, Parkinson's disease and schizophrenia. The primary outcomes will be cancer incidence and cancer mortality in association with a central nervous system disorder. Secondary outcome measures will be site-specific cancer incidence and mortality, respectively. Two reviewers will independently screen references identified by the literature search, as well as potentially relevant full-text articles. Data will be abstracted, and study quality/risk of bias will be appraised by two reviewers independently. Conflicts at all levels of screening and abstraction will be resolved through discussion. Random-effects meta-analyses of primary observational studies will be conducted where appropriate. Parameters for exploring statistical heterogeneity are pre-specified. The World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) criteria and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach will be used for determining the quality of evidence for cancer outcomes. DISCUSSION: Our study will establish the extent of the epidemiological evidence underlying the associations between central nervous system disorders and cancer and will provide a rigorous and updated synthesis of a range of important site-specific cancer outcomes. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42016052762.

Años de vida ajustados por discapacidad perdidos por cardiopatía isquémica en España / Disability-adjusted life years lost to ischemic heart disease in Spain

Introducción y objetivos. Los años de vida ajustados por discapacidad aúnan en una medida consecuencias mortales y no mortales de las enfermedades. El objetivo fue cuantificar la carga de enfermedad de la cardiopatía isquémica en España en 2008 mediante el cálculo de años de vida ajustados por discapacidad. Métodos. Años perdidos por muerte prematura calculados a partir de defunciones por cardiopatía isquémica por edad y sexo del Instituto Nacional de Estadística y tabla de vida del estudio de carga global de enfermedad 2010. Años vividos con discapacidad calculados para el síndrome coronario agudo, la angina estable y la insuficiencia cardiaca isquémica, con datos del registro de altas hospitalarias y de estudios poblacionales, y pesos de discapacidad del estudio de carga global de enfermedad 2010. Se calcularon tasas brutas y estandarizadas por edad (población estándar europea). Se realizaron análisis de sensibilidad univariantes. Resultados. En 2008 se perdieron en España 539.570 años de vida ajustados por discapacidad por cardiopatía isquémica (tasa bruta: 11,8/1.000; estandarizada: 8,6/1.000). El 96% correspondía a años perdidos por muerte prematura y el 4% por discapacidad. De estos últimos, el 83% por insuficiencia cardiaca, el 15% por angina estable y el 2% por síndrome coronario agudo. En el análisis de sensibilidad, el factor que más modificó los resultados fue la ponderación por edad. Conclusiones. La cardiopatía isquémica sigue teniendo un gran impacto en la salud de la población, principalmente por mortalidad prematura. Los resultados aportan una visión global de la situación epidemiológica y pueden servir para evaluar intervenciones sobre las manifestaciones agudas y crónicas de la isquemia cardiaca (AU)

Introduction and objectives. The health indicator disability-adjusted life years combines the fatal and nonfatal consequences of a disease in a single measure. The aim of this study was to evaluate the burden of ischemic heart disease in 2008 in Spain by calculating disability-adjusted life years. Methods. The years of life lost due to premature death were calculated using the ischemic heart disease deaths by age and sex recorded in the Spanish National Institute of Statistics and the life-table in the 2010 Global Burden of Disease study. The years lived with disability, calculated for acute coronary syndrome, stable angina, and ischemic heart failure, used hospital discharge data and information from population studies. Disability weights were taken from the 2010 Global Burden of Disease study. We calculated crude and age standardized rates (European Standard Population). Univariate sensitivity analyses were performed. Results. In 2008, 539 570 disability-adjusted life years were lost due to ischemic heart disease in Spain (crude rate, 11.8/1000 population; standardized, 8.6/1000). Of the total years lost, 96% were due to premature death and 4% due to disability. Among the years lost due to disability, heart failure accounted for 83%, stable angina 15%, and acute coronary syndrome 2%. In the sensitivity analysis, weighting by age was the factor that changed the results to the greatest degree. Conclusions. Ischemic heart disease continues to have a huge impact on the health of our population, mainly because of premature death. The results of this study provide an overall vision of the epidemiologic situation in Spain and could serve as the basis for evaluating interventions targeting the acute and chronic manifestations of cardiac ischemia (AU)

Place of death and associated factors among patients with amyotrophic lateral sclerosis in Madrid (Spain).

Our objectives were to analyse the place of death, its temporal trend and associated sociodemographic factors among patients with amyotrophic lateral sclerosis (ALS) resident in the Autonomous Community of Madrid. This was a population based cross-sectional study of deaths from ALS (ICD-10 code G12.2) from 2003 to 2011, included in regional death statistics. The sociodemographic variables were age, gender, marital status, place of residence and socioeconomic level. Logistic regressions were performed to identify factors associated with death in hospital, and odds ratios (OR) with 95% confidence intervals (CI) were calculated. Joinpoint models were used to analyse annual trends for death in hospital. Of 1035 patients who died of ALS, 56.1% died in a hospital, 30.4% at home, 8.3% in a residential home and it was unknown for 5.1%. The percentage of deaths in hospital was lower in older and in single people than in married ones (55.0% and 61.9%, respectively; ORa 0.74, 95% CI 0.57-0.97). This percentage increased progressively as socioeconomic level fell (66.3% in Q5 compared to 49.6% in Q1, ORa 2.03, 95% CI 1.36-3.02). A significant increase in the percentage of deaths in hospital was observed. In conclusion, factors such as age, marital status or socioeconomic level play a part in the place of death of those with ALS.

[Mobility Exposure Measures in Serious Road Traffic Injuries in Madrid, Spain]. / Medidas de exposición a la movilidad en las lesiones graves por tráfico en la Comunidad de Madrid.

BACKGROUND: The search of suitable indicators for estimating the risk of road traffic injuries is nowadays a relevant topic. The objective of this study was to carry out a comparative description of mortality and inhospital morbidity by age and sex, using population rates and mobility exposure related indicators. METHODS: Cross sectional study in the Community of Madrid, 2003-2005. Population rates and mortality and morbidity rates per billion of persons-kilometers travelled and per million of persons-hours travelled were estimated and compared by age and sex. The Minimum Basic Hospital Discharge Data Set, the 2004 Mobility House Survey of the Community of Madrid and the mortality register of the Statistic Institute of the Community of Madrid were used as information sources. RESULTS: 7,413 hospital discharges and 1,046 deaths were identified. Morbidity and mortality population rates in men were 62.24 and 9.20 respectively, and in women 23.80 and 2.97 per 100,000 inhabitants, being the highest rates those for men aged 16-24 years (119.27 hospital discharges and 12.00 deaths per 100,000 inhabitants). Women of 65 years and older showed the highest mobility related rates: 649.78 hospital discharges and 96.72 deaths per 10(9) km, and 13.11 hospital discharges and 1.95 deaths per 10(6) travelled hours. CONCLUSIONS: Morbidity and mortality were higher in men for the three indicators. Rates referred to mobility exposure, faced to population rates, decrease mortality and morbidity due to road traffic injuries in men and young ages and increase both in advanced ages.

Medidas de exposición a la movilidad en las lesiones graves por tráfico en la Comunidad de Madrid / Mobility Exposure Measures in Serious Road Traffic Injuries in Madrid, Spain

Fundamentos: La búsqueda de indicadores apropiados para estimar el riesgo de lesiones por tráfico es actualmente un área de interés relevante. El objetivo de este estudio fue realizar una descripción de la morbilidad hospitalaria y la mortalidad por lesiones por tráfico en la Comunidad de Madrid, según edad y sexo, utilizando y comparando entre sí tasas por población, por personas-km y por personas-horas. Métodos: Estudio descriptivo transversal en la Comunidad de Madrid referido al período 2003-2005. Se estimaron y compararon por edad y sexo tasas de morbilidad y mortalidad por población, por personas-km recorridos y por personas-horas de desplazamiento. Se utilizaron como fuentes de información el Conjunto Mínimo Básico de Datos Hospitalarios de 2003-2005, la Encuesta Domiciliaria de Movilidad de 2004 en la Comunidad de Madrid y el registro de mortalidad del Instituto de Estadística de la Comunidad de Madrid. Resultados: Se identificaron 7.413 altas hospitalarias y 1.046 defunciones. Las tasas poblacionales de morbilidad hospitalaria y mortalidad fueron de 62,24 y 9,20/100.000 habitantes respectivamente en hombres, y de 23,80 y 2,97/100.000 en mujeres, siendo las más elevadas en varones de 16-24 años (119,27 altas y 12,00 fallecidos por 100.000 habitantes). Las tasas por exposición más altas correspondieron a mujeres de 65 y más años: 649,78 altas y 96,72 fallecidas por 109 km, y 13,11 altas y 1,95 fallecidas por 106 horas de desplazamiento. Conclusiones: La morbi-mortalidad fue mayor en hombres en todos los indicadores. Los indicadores basados en la exposición a la movilidad, frente a las tasas poblacionales, reducen la morbi-mortalidad de lesiones por tráfico en hombres y en edades jóvenes y aumentan la misma en edades avanzadas (AU)

Background: The search of suitable indicators for estimating the risk of road traffic injuries is nowadays a relevant topic. The objective of this study was to carry out a comparative description of mortality and in hospital morbidity by age and sex, using population rates and mobility exposure related indicators. Methods: Cross sectional study in the Community of Madrid, 2003-2005. Population rates and mortality and morbidity rates per billion of persons-kilometers travelled and per million of persons-hours travelled were estimated and compared by age and sex. The Minimum Basic Hospital Discharge Data Set, the 2004 Mobility House Survey of the Community of Madrid and the mortality register of the Statistic Institute of the Community of Madrid were used as information sources. Results: 7,413 hospital discharges and 1,046 deaths were identified. Morbidity and mortality population rates in men were 62.24 and 9.20 respectively, and in women 23.80 and 2.97 per 100,000 inhabitants, being the highest rates those for men aged 16-24 years (119.27 hospital discharges and 12.00 deaths per 100,000 inhabitants). Women of 65 years and older showed the highest mobility related rates: 649.78 hospital discharges and 96.72 deaths per 109 km, and 13.11 hospital discharges and 1.95 deaths per 106 travelled hours. Conclusions: Morbidity and mortality were higher in men for the three indicators. Rates referred to mobility exposure, faced to population rates, decrease mortality and morbidity due to road traffic injuries in men and young ages and increase both in advanced ages (AU)

Disability-adjusted Life Years Lost to Ischemic Heart Disease in Spain.

INTRODUCTION AND OBJECTIVES: The health indicator disability-adjusted life years combines the fatal and nonfatal consequences of a disease in a single measure. The aim of this study was to evaluate the burden of ischemic heart disease in 2008 in Spain by calculating disability-adjusted life years. METHODS: The years of life lost due to premature death were calculated using the ischemic heart disease deaths by age and sex recorded in the Spanish National Institute of Statistics and the life-table in the 2010 Global Burden of Disease study. The years lived with disability, calculated for acute coronary syndrome, stable angina, and ischemic heart failure, used hospital discharge data and information from population studies. Disability weights were taken from the 2010 Global Burden of Disease study. We calculated crude and age standardized rates (European Standard Population). Univariate sensitivity analyses were performed. RESULTS: In 2008, 539 570 disability-adjusted life years were lost due to ischemic heart disease in Spain (crude rate, 11.8/1000 population; standardized, 8.6/1000). Of the total years lost, 96% were due to premature death and 4% due to disability. Among the years lost due to disability, heart failure accounted for 83%, stable angina 15%, and acute coronary syndrome 2%. In the sensitivity analysis, weighting by age was the factor that changed the results to the greatest degree. CONCLUSIONS: Ischemic heart disease continues to have a huge impact on the health of our population, mainly because of premature death. The results of this study provide an overall vision of the epidemiologic situation in Spain and could serve as the basis for evaluating interventions targeting the acute and chronic manifestations of cardiac ischemia.

The national burden of cerebrovascular diseases in Spain: a population-based study using disability-adjusted life years / Carga de las enfermedades cerebrovasculares en España: estudio de base poblacional utilizando los años de vida ajustados por discapacidad

Background and objective: The aim of the present study was to determine the national burden of cerebrovascular diseases in the adult population of Spain. Patients and methods: Cross-sectional, descriptive population-based study. We calculated the disability-adjusted life years (DALY) metric using country-specific data from national statistics and epidemiological studies to obtain representative outcomes for the Spanish population. DALYs were divided into years of life lost due to premature mortality (YLLs) and years of life lived with disability (YLDs). DALYs were estimated for the year 2008 by applying demographic structure by sex and age-groups, cause-specific mortality, morbidity data and new disability weights proposed in the recent Global Burden of Disease study. In the base case, neither YLLs nor YLDs were discounted or age-weighted. Uncertainty around DALYs was tested using sensitivity analyses. Results: In Spain, cerebrovascular diseases generated 418,052 DALYs, comprising 337,000 (80.6%) YLLs and 81,052 (19.4%) YLDs. This accounts for 1,113 DALYs per 100,000 population (men: 1,197 and women: 1,033) and 3,912 per 100,000 in those over the age of 65 years (men: 4,427 and women: 2,033). Depending on the standard life table and choice of social values used for calculation, total DALYs varied by 15.3% and 59.9% below the main estimate. Conclusions: Estimates provided here represent a comprehensive analysis of the burden of cerebrovascular diseases at a national level. Prevention and control programmes aimed at reducing the disease burden merit further priority in Spain (AU)

Fundamento y objetivo: El objetivo del presente estudio fue determinar la carga de las enfermedades cerebrovasculares en la población adulta española. Pacientes y métodos: Estudio transversal descriptivo de base poblacional. Se calcularon los años de vida ajustados por discapacidad (AVAD) utilizando datos específicos nacionales procedentes de estadísticas y estudios epidemiológicos para obtener resultados representativos a nivel nacional. Los AVAD fueron divididos en años de vida perdidos (AVP) y años vividos con discapacidad (AVD). Los AVAD fueron estimados para el año 2008 mediante la aplicación de la estructura demográfica por sexo y grupos de edad, la mortalidad por causas específicas, los datos de morbilidad y los nuevos pesos de discapacidad que se proponen en el reciente estudio de la carga global de enfermedades. En el caso base, los AVP y los AVD no fueron descontados ni ponderados por edad. La incertidumbre en torno a los AVAD se examinó mediante análisis de sensibilidad. Resultados: En España, las enfermedades cerebrovasculares generaron 418.052 AVAD, incluyendo 337.000 (80,6%) AVP y 81.052 (19,4%) AVD. Esto representa 1.113 AVAD por 100.000 habitantes (1.197 hombres y 1.033 mujeres) y 3.912 por 100.000 en los mayores de 65 años (4.427 hombres y 2.033 mujeres). En función de la tabla de vida estándar y la elección de las valoraciones sociales utilizadas en los cálculos, los AVAD totales variaron entre un 15,3 y un 59,9% por debajo de los resultados principales. Conclusiones: Las estimaciones proporcionadas aquí representan un análisis exhaustivo de la carga de las enfermedades cerebrovasculares a nivel nacional. Los programas de prevención y control para reducir la carga de enfermedad cerebrovascular merecen una mayor prioridad en España (AU)

The national burden of cerebrovascular diseases in Spain: a population-based study using disability-adjusted life years.

BACKGROUND AND OBJECTIVE: The aim of the present study was to determine the national burden of cerebrovascular diseases in the adult population of Spain. PATIENTS AND METHODS: Cross-sectional, descriptive population-based study. We calculated the disability-adjusted life years (DALY) metric using country-specific data from national statistics and epidemiological studies to obtain representative outcomes for the Spanish population. DALYs were divided into years of life lost due to premature mortality (YLLs) and years of life lived with disability (YLDs). DALYs were estimated for the year 2008 by applying demographic structure by sex and age-groups, cause-specific mortality, morbidity data and new disability weights proposed in the recent Global Burden of Disease study. In the base case, neither YLLs nor YLDs were discounted or age-weighted. Uncertainty around DALYs was tested using sensitivity analyses. RESULTS: In Spain, cerebrovascular diseases generated 418,052 DALYs, comprising 337,000 (80.6%) YLLs and 81,052 (19.4%) YLDs. This accounts for 1,113 DALYs per 100,000 population (men: 1,197 and women: 1,033) and 3,912 per 100,000 in those over the age of 65 years (men: 4,427 and women: 2,033). Depending on the standard life table and choice of social values used for calculation, total DALYs varied by 15.3% and 59.9% below the main estimate. CONCLUSIONS: Estimates provided here represent a comprehensive analysis of the burden of cerebrovascular diseases at a national level. Prevention and control programmes aimed at reducing the disease burden merit further priority in Spain.

La carga de enfermedad atribuible a los principales factores de riesgo en los países de Europa occidental: el reto de controlar los factores de riesgo cardiovascular / No disponible

No disponible

Carga de enfermedad en adolescentes y jóvenes en España / Burden of disease in adolescents and young people in Spain

Objetivo. Se analiza la carga de enfermedad de los adolescentes y jóvenes en España en el año 2008. Material y métodos. Estudio transversal de base poblacional. Se estiman los años de vida ajustados por discapacidad (AVAD) por sexo y causa específica en personas de 15-29 años. Las fuentes de información fueron: 1) Defunciones por edad, sexo y causa; 2) Estimaciones de la población a julio de 2008; y 3) Estimaciones del patrón de discapacidad para países europeos con baja mortalidad. Resultados. En 2008, los adolescentes y jóvenes perdieron 786.479 AVAD (414.346 en varones). Las enfermedades no transmisibles causaron 661.282 AVAD (84% respecto al total). Las principales causas específicas de carga de enfermedad fueron: depresión (16% de AVAD), abuso de alcohol (11%), migrañas (9%), trastorno bipolar (7%), esquizofrenia (6%), accidentes de circulación (5%) y adicción a drogas (5%). Conclusiones. La carga de enfermedad expresada en AVAD permite definir las pérdidas de salud en adolescentes y jóvenes. A estas edades, la promoción y protección de la salud son fundamentales, para prevenir la aparición de enfermedades en el adulto(AU)

Objective. This article analyses the burden of disease in adolescents and young people in Spain in 2008. Materials and methods. A cross-sectional population-based study. We estimated disability-adjusted life years (DALYs) by sex and cause for subjects aged 15-29 years. Data sources were used: (1) National death records by age, sex and cause; (2) population data (both in July 2008); and (3) estimates of the disability pattern for European countries with very low mortality. Results. In 2008, adolescents and young people lost 786,479 DALYs (414,346 in males). Non-communicable diseases generated 661,282 DALYs (84% of the total). The main specific causes of disease burden were: unipolar depression (16% of DALYs), alcohol use disorders (11%), migraine (9%), bipolar disorder (7%), schizophrenia (6%), road traffic accidents (5%) and drug addiction disorders (5%). Conclusions. The burden of disease expressed in DALYs can define the loss of health in adolescents and young people. At these ages, health promotion and protection are essential to prevent the onset of disease in adulthood(AU)

La prevención y el control de las enfermedades crónicas no transmisibles en España: una llamada para la acción / Prevention and control of chronic non-communicable diseases in Spain: A call to action

No disponible

Evaluación de la carga de enfermedad con medidas sintéticas de salud de la población para la Comunidad Valenciana, España: un estudio de base poblacional / Burden of disease assessment with summary measures of population health for the Region of Valencia, Spain: a population-based study

Fundamento y objetivo: La descripción consistente y comparativa del estado de salud de la población es importante para la toma de decisiones y la planificación sanitaria. El objetivo de este estudio fue describir la carga de enfermedad en la Comunidad Valenciana. Material y métodos: Se calcularon los años de vida ajustados por discapacidad (AVAD), que se dividen en años de vida perdidos (AVP) y años vividos con discapacidad (AVD). Utilizando información procedente del registro de mortalidad y de las estimaciones de la población valenciana en el año 2008, se calculó el número de muertes y AVP. Los AVD se basan en datos específicos por sexo y edad de los países de la sub-región EURO-A (que incluye a la Comunidad Valenciana) del estudio de Carga Global de Enfermedad. Los resultados fueron estratificados por grupos de edad, sexo y causa de muerte. Los valores de AVAD se utilizaron para clasificar las condiciones que producen mayor carga de enfermedad. Resultados: En 2008, se perdieron un total 551 mil AVAD (53% en hombres). Las principales categorías en AVAD perdidos fueron las enfermedades neuropsiquiátricas (167 mil [30% del total de AVAD]), los tumores malignos (85 mil [15%]), las enfermedades cardiovasculares (72 mil [13%]) y las enfermedades de los órganos de los sentidos (46 mil [8%]). La depresión (47 mil [8% de AVAD]), las demencias (42 mil [8%]), la cardiopatía isquémica (27 mil [5%]), las pérdidas de audición (22 mil [4%]), el accidente cerebrovascular (20 mil [4%]) y el cáncer de pulmón (19 mil [3%]) fueron las principales causas específicas de carga de la enfermedad. Conclusiones: Se proporciona información por primera vez sobre la carga de enfermedad en la población valenciana. A este nivel local, el uso de los AVAD puede ayudar a monitorizar el estado de salud de la población y guiar los debates sobre el establecimiento de prioridades (AU)

Background and objective: An important input to decision-making and health planning is a consistent and comparative description of the population health status. The purpose of this study was to describe the burden of disease in the Region of Valencia (Spain). Material and methods: Disability-adjusted life years (DALYs) were calculated and divided into years of life lost (YLLs) and years lived with disability (YLDs). Using death registry data and Valencian population estimates in 2008, we calculated the number of deaths and YLLs. YLDs were based on age- and sex-specific data for countries of the EURO-A subregional level (which includes the Region of Valencia) from the Global Burden of Disease study. The results were stratified by age group, sex and underlying cause of death. The DALY values were used to rank the leading conditions of disease burden. Results: In 2008, the total number of DALYs lost was about 551 thousands (53% in men). The main categories of DALYs lost were neuropsychiatric conditions (30%; 167 thousands), malignant tumors (15%; 85 thousands), cardiovascular diseases (13%; 72 thousands) and sense organ diseases (8%; 46 thousands). Depression (8% of DALYs; 47 thousands), dementias (8%; 42 thousands), ischaemic heart disease (5%; 27 thousands), hearing loss (4%; 22 thousands), stroke (4%; 20 thousands) and lung cancer (3%; 19 thousands) were the leading specific causes of disease burden. Conclusions: We provide for the first time ever information on the burden of disease in the Valencian population. At this local level, the use of DALYs can help to monitor the population health status and guide the debates on rational priority-setting (AU)